122292-69-7

Upstream product

• 132335-80-9 (1R,2S,3R,4aR,9aR)-5,6-O-diphenylmethylidene-1,2,3,4,4a,9a-hexahydro-2,3-O-isopropylidene-3-methyl-9,10-dioxo-1-(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyloxy)anthracene-2,3,5,6,8-pentaol 
• 122204-19-7 (1R,2S,3R)-5,6-O-diphenylmethylidene-1,2,3,4-tetrahydro-2,3-O-isopropylidene-3-methyl-9,10-dioxo-1-(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyloxy)anthracene-2,3,5,6,8-pentaol 
• 186581-53-3 diazomethane 

Downstream Products

• 1384651-40-4 6-(benzylamino)-6-demethoxybostrycin 
• 1384651-42-6 6-(p-fluorobenzylamino)-6-demethoxybostrycin 
• 1384651-35-7 6-(phenylamino)-6-demethoxybostrycin 
• 1384651-41-5 6-(p-methoxybenzylamino)-6-demethoxybostrycin 
• 1384651-38-0 6-(p-methoxyphenylamino)-6-demethoxybostrycin 
• 1384651-49-3 6-(4'-phenylpiperidin-1-yl)-6-demethoxybostrycin 

Relevant academic research and scientific papers

An enantioselective synthesis of (+)-bostrycin leading to a revision of the absolute configuration of its natural antipode

An asymmetric Diels-Alder reaction, involving the protected naphthopurpurin (4) and the D-glucose-derived diene (9a), is used to assemble compound (22), which is transformed by way of compounds (26), (27) and (28) into (+)-bostrycin (3). An X-ray analysis